Pegfilgrastim biosimilar (mochida) | Interleukin Related interleukin-related.com

Product Name :
Pegfilgrastim biosimilar (mochida)

Search keywords :
G-CSF Receptor

drugId :
null

Target Vo:
Colony stimulating factor 3 receptor

Target Vo Short Name :
CSF3R

Moa_Name:
Colony stimulating factor 3 receptor agonists

First Approval Country :
Japan

First Approval Date Filter:
2023

Origin Company_Name :
Mochida Pharmaceutical Co Ltd

Active Company_Name :
Mochida Pharmaceutical Co Ltd

Active Indication_Name:
Febrile Neutropenia

In Active Indication_Name:
Chemotherapy-Induced Febrile Neutropenia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JNK1 Antibody (YA720)
Glutathione Peroxidase 4 Antibody
Cleaved-PARP1 Antibody: Cleaved-PARP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to Cleaved-PARP1. It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts